Krystal Biotech (NASDAQ:KRYS) reported strong quarterly results, with shares rising 4.3% to US$183. Analysts predict revenue growth of 91% to US$461.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
